The culture was spread onto selective medium containing ampicillin
South Med J 1979;72:83741.doi:10.1097/00007611-197907000-00021[PubMed] 2
Our team of highly trained professionals is committed to delivering top-quality care, attention, and service you deserve
Short-term trials (412 weeks) report transient headaches in 1218% of participants and mild GI discomfort in 8%, with zero serious adverse events requiring discontinuation
Together, these medications may help manage weight more effectively than either one alone
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide were studied in STEP (semaglutide, weight management, NEJM 2021), SURMOUNT (tirzepatide, weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide, obstructive sleep apnea, NEJM 2024)